Science
Mechanism of Action
Upon topical application, Isopropyl Nicotinate readily penetrates the epidermis where it is hydrolyzed into its active metabolite, nicotinic acid. This active form selectively activates the G protein-coupled receptor 109A (GPR109A), also known as HCAR2, located on epidermal cells such as keratinocytes and Langerhans cells. This receptor activation initiates the arachidonic acid cascade, leading to the synthesis and release of prostaglandins, specifically Prostaglandin D2 (PGD2) and Prostaglandin E2 (PGE2). These prostaglandins subsequently act on vascular smooth muscle, inducing vasodilation, increasing localized blood flow, and manifesting as visible skin reddening (erythema).
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
The primary degradation pathway involves hydrolysis of the ester bond, yielding nicotinic acid and isopropanol, a process accelerated by both acidic and basic conditions. To optimize stability, formulations should be buffered to a slightly acidic to neutral pH range. Elevated temperatures significantly accelerate degradation, necessitating storage at controlled room temperature and protection from excessive heat. Light exposure may also contribute to degradation, suggesting the use of opaque or amber-colored packaging.
Conflicts
- acids
- bases
- metal ions
Safety
Safety Profile
Isopropyl Nicotinate is registered in the FDA's Global Substance Registration System. Its EPA TSCA Commercial Activity Status is 'INACTIVE'. According to GHS classification, it is categorized as causing skin irritation (H315), serious eye irritation (H319), and potentially respiratory irritation (H335).
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to its mechanism inducing significant skin reddening and high irritancy classification, Isopropyl Nicotinate is generally recommended to be avoided in skincare formulations for broad consumer use.
Related
Similar Ingredients
Finding similar ingredients…